Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial #FOAMed

This trial is worth a read. Courtesy of critical care (Click Icon) Basically They wanted to see whether sepsis-associated ARDS patients had better outcomes when given Hydrocortisone therapy. Methods They randomised patients to receive either hydrocortisone 50 mg every 6 h or placebo. What they demonstrated The patients who got hydrocortisone had significant improvement P:F ratios and... Continue Reading →

Powered by WordPress.com.

Up ↑